For individuals battling Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a debilitating condition, the arrival of this treatment and Tafamidis meglumine represents a genuine change. These groundbreaking therapies protect the transthyretin protein, preventing its destructive build-up and lessening the burden of the disease . People are now experi… Read More